Painreform Ltd. financial data

Symbol
PRFX on Nasdaq
Industry
Pharmaceutical Preparations
Location
65 Yigal Alon St., Tel Aviv, Israel
State of incorporation
Israel
Fiscal year end
December 31
Latest financial report
20-F - Q4 2024 - Apr 7, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.47M shares -14.9%
Common Stock, Shares, Outstanding 1.47M shares +789%
Common Stock, Value, Issued 0 USD

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.26M USD -46.9%
Assets, Current 4.43M USD -54.8%
Property, Plant and Equipment, Net 35K USD -7.9%
Operating Lease, Right-of-Use Asset 62K USD -33.3%
Assets 4.53M USD -54.4%
Employee-related Liabilities, Current 197K USD -57.6%
Accrued Liabilities, Current 1.9M USD +14.1%
Liabilities, Current 2.44M USD +1.33%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 2.7M USD +0.37%
Retained Earnings (Accumulated Deficit) -56.5M USD -34.8%
Stockholders' Equity Attributable to Parent 1.82M USD -74.8%
Liabilities and Equity 4.53M USD -54.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 2.5M shares +1100%
Common Stock, Shares, Issued 1.47M shares +789%
Common Stock, Par or Stated Value Per Share 0.3 ILS/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.27M USD -46.9%
Deferred Tax Assets, Valuation Allowance 10.2M USD +48%
Operating Lease, Liability, Current 45K USD -19.6%
Deferred Tax Assets, Operating Loss Carryforwards 7.96M USD +39.8%
Unrecognized Tax Benefits 259K USD +3.19%
Additional Paid in Capital 58.3M USD +18.7%
Deferred Tax Assets, Net of Valuation Allowance 0 USD